-

RMB Capital’s Shareholder Proposal (Share Buyback) Gained 11% Support at Nishikawa’s Annual General Shareholders Meeting

CHICAGO--(BUSINESS WIRE)--RMB Capital (“RMB”), a Chicago-based independent investment advisory firm, is a long-term shareholder of Nishikawa Rubber Industry Co., Ltd. (5161 JP, “Nishikawa”) and owns approximately 2% of the firm’s total outstanding shares.

RMB had filed a shareholder proposal (Proposal #6) for Nishikawa’s 71st annual general shareholders meeting, held on June 25, 2020, to buy back common stock of 88,000 shares, maximum 100 million yen. Despite the limited number of minority shareholders at the firm, RMB’s proposal gained 10.52% support from attending shareholders. In addition, 10.89% of attending shareholders voted against the continuation of the “poison pill” proposed by the management (item #5), along with RMB’s opposition.

RMB intends to keep engaging with Nishikawa’s management to improve the shareholder value.

About RMB Capital

Headquartered in Chicago, RMB Capital is an independent investment advisory firm that serves high-net-worth individuals and families as well as institutional investors. Its businesses include wealth management, family office services, asset management, and retirement plan consulting. Its asset management business specializes in long-term, concentrated, active investing strategies with coverage that spans the market-cap spectrum and the globe. To learn more about RMB, visit https://rmbcapital.com.

Contacts

Masakazu Hosomizu
RMB Capital
japan@rmbcap.com

RMB Capital


Release Summary
RMB Capital's share buyback proposal received 11% support at Nishikawa’s annual general shareholders meeting.
Release Versions

Contacts

Masakazu Hosomizu
RMB Capital
japan@rmbcap.com

More News From RMB Capital

Curi RMB Capital Demands JAE Cancel Tender Offer and Evaluate Alternative Buyout Offers

CHICAGO--(BUSINESS WIRE)--Curi RMB Capital demands that Japan Aviation Electronics Industry, Ltd. (6807 JP) cancel its tender offer and evaluate alternative buyout offers....

Curi RMB Capital Opposes Taisho Pharmaceutical HD's Management Buyout

CHICAGO--(BUSINESS WIRE)--Curi RMB Capital opposes the management buyout of Taisho Pharmaceutical Holdings Co., Ltd. (4581 JP, TSE Standard, “Taisho”)...

Curi Capital and RMB Capital Complete Merger

CHICAGO & RALEIGH, N.C.--(BUSINESS WIRE)--Curi has confirmed the completion of its previously announced acquisition of RMB Capital and the merger between Curi Capital and RMB Capital....
Back to Newsroom